SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Guilford (GLFD) - Steadily Rising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ken carney who wrote (27)2/26/1997 6:54:00 AM
From: Dr. Bob   of 496
 
I didn't think so; the Gliadel product had been approved earlier, which was the big news. This announcement was simply that RPR was ready to sell it. It'll take a couple months, I would think, for an indication of how well it's selling, so that some predictions could be made of how it will affect GLFD's bottom line. A lot of that is already priced into the stock I think, so more, non-Gliadel news is what I would think it will take to take GLFD to the next level (i.e., mid-30's).

Bob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News